Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pancreatic Cystic Lesions clinical trials
2 of 3 indexed Pancreatic Cystic Lesions trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Pancreatic Cystic Lesions: 3 US clinical trials tracked, 2 recruiting.
Pancreatic Cystic Lesions is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Amplified Sciences, running 1 of these trials.
Enrollment posture brief
Registry condition pancreatic-cystic-lesions
OPEN 2 | RECR 67% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Pancreatic Cystic Lesions lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pancreatic Cystic Lesions on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pancreatic Cystic Lesions is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions
The University of Texas Health Science Center, Houston
NCT02647177
A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions
Amplified Sciences
NCT06894329
Evaluation of PCLs Using Three EUS-FNA Needles
Boston Scientific Corporation
NCT01711294
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Pancreatic Cystic Lesions records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pancreatic Cystic Lesions trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pancreatic Cystic Lesions page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Pancreatic Cystic Lesions trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Amplified Sciences sponsors the most Pancreatic Cystic Lesions trials on record, review their full trial history before evaluating a specific study. See Amplified Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pancreatic Cystic Lesions condition card totals 3 registered trials; most-linked intervention 19 G Needle; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.